[May medical therapy of arterial hypertension by used in patients with renal failure?].
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003981:Diazoxide / Q000627:therapeutic use; D004361:Drug Tolerance; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D006977:Hypertension, Renal / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000188:drug therapy; D008750:Methyldopa / Q000627:therapeutic use; D012039:Regional Blood Flow; D014655:Vascular Resistance
D000959:Antihypertensive Agents; D006830:Hydralazine; D008750:Methyldopa; D003981:Diazoxide; D006145:Guanethidine
La thérapeutique médicamenteuse de l'hypertension artérielle peut-elle utilisée chez les insuffisants rénaux?